“SCANDENS PHARMACEUTİCAL İNDUSTRİES Ltd” – the first pharmaceutical plant for the complete production cycle of Pharmaceutical formulations in Azerbaijan was established in 2016. Construction of the plant started in 2017.
The first stage of production involves solid medicines forms including tablets, capsules and granules over the full production cycle from granulation to finished products and batch release from its own Quality Control laboratory as well as its high standard Quality system.
The second stage will be for Manufacturing and release of ointments and suppositories.
The third stage is targeted to the sterilized products – ampoules for injection and infusion solutions.
“Scandens Pharmaceuticals İndustries Ltd” offers large cooperation opportunities with other pharmaceutical companies in the areas of producers of manufacturing based on technology transfer, licensed production, and contract production.
The plant is designed by one of the leading consulting companies engaged in the pharmaceutical field who has more than 400 pharmaceutical successfully operating plants into their credit in various countries across the globe.
Plant current designed production capacity in the first stage is 600 million tablets and 150 million capsules, which will provide the need for tablet and capsule medicine forms of many therapeutic groups, such as cardiology, antidiabetic, anti-tuberculosis, analgesic, anti-inflammatory and others. More than 100 generic formulations are being planned to produce.
“Scandens Pharmaceutical Industries Ltd.”
has the following strategic opportunities for entering the Azerbaijan and surrounding pharmaceutical market:
- Being a local manufacturing company Scandens offer a low inventory and lower cost product of international standard for the Institutional and government purchasing programs.
- Scandens can offer low volume products due to its versatile production capacity which is difficult to import due to large MOQ (Minimal Order Quantity) for market from the international vendors.
- Scandens can manufacture new high technology products with a minimum possible quantity for launch and further development.
- Scandens can produce pharmaceutical products in cooperation with other pharmaceutical companies.
- Due to the presence of full technological production cycle, Manufacturing with transfer of technology.
- Contract manufacturing of products on “Scandens” facilities.
- Production of “Scandens” trade marks in other manufacturing facilities in bulk and doing the partial production and batch release at local site.
- Scandens can manufacture bulk tablets or capsules and export to other companies.
- Scandens can manufacture products of large companies under license.
- Blisters packaging and inserting leaflets on the local language into packages can also be offered as a business opportunity by Scandens.
- Possibility of entering to other pharmaceutical markets:
- Having good commercial relation with Uzbekistan, Kazakhstan, Turkmenistan, Tajikistan, Kirgizstan, Russia Federation and Iran also, will help large multinational companies to enter these markets with minimum primary volumes from “Scandens”.
Our vision is to provide high-quality products to meet customers’ expectations, and to bring the technology of Pharmaceutical manufacturing to Azerbaijan thus creating an organization wherein people will be inspired, interested and motivated, and creating opportunities for their fully use of talent and energy.